•  
  •  
  •  
  •  

2025-10-04 19:15:01

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand

Keywords Selected:  LupinLimited

Stock Report

  • Lupin Ltd recommends dividend of Rs. 4
  • Lupin and Biomm Enter into a Distribution and Marketing Agreement for Pegfilgrastim in Brazil
  • Lupin partners with TTP plc UK for Soft-mist Inhalation Technology Platform
  • Lupin launches Sciflix a mobile-friendly learning platform for post graduate students specializing in pulmonology
  • Lupin Raises Awareness about Mental Health by Partnering with Singer Shaan to Relaunch the Iconic Song 'Tanha Dil Tanha Safar'
  • Lupinlife's Be One wins the best packaging design, graphics and brand value add award at the India Packaging Awards 2021
  • Lupin Launches Authorized Generic Version of Antara® in the United States
  • Lupin's Namuscla® is recommended by NICE for treatment of symptomatic myotonia in adults with non-dystrophic myotonic disorders
  • Lupin Receives Tentative Approval from U.S. FDA for Brexpiprazofe Tablets

Latest Post

  • Pyramid Technoplast Ltd announces commencement of its Unit IX - Recycling plant
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • Uni Abex Alloy Products Ltd to sell land at Thane for Rs. 244.23 crores
  • Kesar India Ltd purchases land at Nagpur
  • Uflex Ltd commissions enhanced capacity at Sanand


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024